Amos Stemmer

Evaluation of Seropositivity Following BNT162b2 Messenger RNA Vaccination for SARS-CoV-2 in Patients Undergoing Treatment for Cancer

Amir Massarweh, Noa Eliakim‐Raz, Amos Stemmer et al. · JAMA Oncology · 2021 · 282 citations · Full text

Antibody Titers Before and After a Third Dose of the SARS-CoV-2 BNT162b2 Vaccine in Adults Aged ≥60 Years

Noa Eliakim‐Raz, Yaara Leibovici-Weisman, Amos Stemmer et al. · JAMA · 2021 · 115 citations · Full text

Durability of Response to SARS-CoV-2 BNT162b2 Vaccination in Patients on Active Anticancer Treatment

Noa Eliakim‐Raz, Amir Massarweh, Amos Stemmer et al. · JAMA Oncology · 2021 · 52 citations · Full text

Real-world evidence for immunotherapy in the first line setting in small cell lung cancer

Shira Sagie, Nitzan Maixner, Amos Stemmer et al. · Lung Cancer · 2022 · 34 citations

Cancer Immunosurveillance, Medicine, First Line +11

Antibody Titers After a Third and Fourth SARS-CoV-2 BNT162b2 Vaccine Dose in Older Adults

Noa Eliakim‐Raz, Amos Stemmer, Nassem Ghantous et al. · JAMA Network Open · 2022 · 29 citations · Full text

Vaccination, Antibody Titers, Vaccine Development +10